Tomofusa Fukuyama

Director, Professor

International University of Health and Welfare

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Tomofusa Fukuyama serves as the Director at the International University of Health and Welfare in Japan. His research focuses on hematopoietic cell differentiation and leukemia, with recent publications addressing pathways related to MLL-fusion leukemia, myeloid differentiation, and chronic myeloid leukemia stem cells. His work also explores the role of histone modifiers and their impact on hematopoietic cells and tumor progression.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Yasutaka Hayashi

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomofusa Fukuyama

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia

MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8

CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression

Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With <i>MLL</i> Gene Amplification: A Case Report and Literature Review

A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells

Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells

Collaborators (1)

Yasutaka Hayashi

Make your next move.